cortivazol Report issue

Small molecule Experimental
AACT ChEMBL DrugBank Drug Central KEGG MeSH PubChem

Active Ingredient History

NOW
  • Now
Cortivazol is a high-affinity agonist ligand for the glucocorticoid receptor and consequently is classified as a glucocorticoid.   Wikipedia

Chemistry

  • SMILES: CC(=O)OCC(=O)[C@@]1(O)[C@H](C)C[C@H]2[C@@H]3C=C(C)C4=Cc5c(cnn5-c5ccccc5)C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C
  • InChIKey: RKHQGWMMUURILY-UHRZLXHJSA-N
  • Mol. Mass: 530.67
  • ALogP: 4.3
  • ChEMBL Molecule:
    cortivazol  
More Chemistry

Pharmacology

Alternative names

11 beta,17 alpha,21- trihydroxy-6,16 alpha-dimethyl-2'-phenylpregna- 2,4,6-trieno(3,2-c)pyrazol-20-one 21-acetate | altim | cortivazol | dilaster | h-3625 | idaltim

Organizations (4)

Research & Development (4)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (3)

Approved Indications (1)


 

Leukemia

Experimental Indications - Clinical Trial Phases 1-4 (2)


 

Cluster Headache (Phase 2/Phase 3)

Sciatica (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial Organizations: 4

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue